Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Diabetic Nephropathy | Research

Epidemiological analysis of death among patients on maintenance hemodialysis: results from the beijing blood purification quality Control and Improvement Center

Authors: Jing Liu, Huixian Zhang, Zongli Diao, Wang Guo, Hongdong Huang, Li Zuo, Wenhu Liu

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

China has the largest number of patients on maintenance hemodialysis (MHD) worldwide. Despite continuous improvements in hemodialysis techniques, patients on MHD have a higher mortality rate than the general population. Understanding the characteristics of death in this population can better promote clinical practice, thereby improving patients’ survival.

Methods

We collected demographic and clinical data for patients on MHD registered in the Beijing Blood Purification Quality Control and Improvement Center database from 2014 to 2020. The annual mortality rate was calculatedand the primary cause of end-stage renal disease (ESRD), dialysis vintage, and cause of death among deceased patients were analyzed.

Results

(1) 24,363 patients on MHD were included, of which 6,065 patients died from 2014 to 2020. The annual mortality rate fluctuated between 7.4% and 8.0%. The median age of death was 70.0 (60.8–79.0) years and the male to female ratio was 1.27:1 (2). The top three primary causes of ESRD in deceased patients were chronic glomerulonephritis (CGN), diabetic nephropathy (DN), and hypertensive nephropathy (HN). Comparison of the annual mortality rate showed DN > HN > CGN (3). The median dialysis vintage of deceased patients was 3.7 (1.8–6.9) years, which slowly increased annually. Patients with diabetes had a shorter dialysis vintage than patients without diabetes (3.4 vs. 4.1 years, Z = 8.3, P < 0.001) (4). The major causes of death were cardiovascular disease (20.2%), sudden death (18.1%), infection (17.9%), and cerebrovascular disease (12.6%). Proportions of death from cardiovascular disease, infection, and sudden death were higher in patients with diabetes (22.2%, 20.2%, and 20.0%) than patients without diabetes (18.4%, 15.8%, and 16.3%). Sudden death was the leading cause of death in young (18–44 years; 27.0%) and middle aged (45–64 years; 20.8%) patients, whereas infection was the leading cause of death in patients aged ≥ 75 years (24.5%).

Conclusion

The annual mortality rate of patients on MHD in Beijing was relatively stable from 2014 to 2020. Sudden death was more likely to occur in young and middle-aged patients, and more patients aged ≥ 75 years died from infections.
Literature
1.
go back to reference Xiangmei Chen. Current status and future of the development of nephrology in China. China Med News. 2021;36(05):19–9. Xiangmei Chen. Current status and future of the development of nephrology in China. China Med News. 2021;36(05):19–9.
2.
go back to reference Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, et al. China kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10(2):e97–7185.CrossRefPubMed Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, et al. China kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10(2):e97–7185.CrossRefPubMed
3.
go back to reference Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomović F, Golan E, et al. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J. 2021;14(1):107–23.CrossRefPubMed Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomović F, Golan E, et al. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J. 2021;14(1):107–23.CrossRefPubMed
4.
go back to reference Cheng X, Nayyar S, Wang M, Li X, Sun Y, Huang W, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant. 2013;28(3):724–32.CrossRefPubMed Cheng X, Nayyar S, Wang M, Li X, Sun Y, Huang W, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant. 2013;28(3):724–32.CrossRefPubMed
5.
go back to reference Yonglong Min S, Fei D, He, et al. Epidemiological analysis of patients who died of hemodialysis in Wuhan. Chin J Blood Purif. 2020;19(08):562–65. Yonglong Min S, Fei D, He, et al. Epidemiological analysis of patients who died of hemodialysis in Wuhan. Chin J Blood Purif. 2020;19(08):562–65.
6.
go back to reference Zhang W, Qian J. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purif. 2012;11(05):233–36. Zhang W, Qian J. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purif. 2012;11(05):233–36.
7.
go back to reference Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. incidence, prevalence, and mortality. Ren Replace Ther. 2020;6(1):41–1. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data,. Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. incidence, prevalence, and mortality. Ren Replace Ther. 2020;6(1):41–1. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data,.
8.
go back to reference Johansen KL, Chertow GM, Gilbertson DT, et al. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022;79(4 Suppl1):A8–A12. US Renal Data System 2021 Annual Data Report:. Johansen KL, Chertow GM, Gilbertson DT, et al. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022;79(4 Suppl1):A8–A12. US Renal Data System 2021 Annual Data Report:.
9.
go back to reference Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, et al. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J Am Soc Nephrol. 2013;24(9):1493–502.CrossRefPubMedPubMedCentral Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, et al. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J Am Soc Nephrol. 2013;24(9):1493–502.CrossRefPubMedPubMedCentral
10.
go back to reference Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009;53(3):475–91.CrossRefPubMed Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009;53(3):475–91.CrossRefPubMed
11.
go back to reference Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.CrossRefPubMedPubMedCentral Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.CrossRefPubMedPubMedCentral
12.
go back to reference Sato T, Sakurai H, Okubo K, Kusuta R, Onogi T, Tsuboi M. Current state of dialysis treatment and vascular access management in Japan. J Vasc Access. 2019;20(1suppl):10–4.CrossRefPubMed Sato T, Sakurai H, Okubo K, Kusuta R, Onogi T, Tsuboi M. Current state of dialysis treatment and vascular access management in Japan. J Vasc Access. 2019;20(1suppl):10–4.CrossRefPubMed
13.
go back to reference Mortality. Causes of death among hemodialysis patients over the years. Chin J Blood Purif. 2012;11(z1):15–25. Mortality. Causes of death among hemodialysis patients over the years. Chin J Blood Purif. 2012;11(z1):15–25.
14.
go back to reference Zou Y, Hong D, He Q, Wen Y, Li G. Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China. Ren Fail. 2019;41(1):644–49.CrossRefPubMedPubMedCentral Zou Y, Hong D, He Q, Wen Y, Li G. Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China. Ren Fail. 2019;41(1):644–49.CrossRefPubMedPubMedCentral
15.
go back to reference Jing Li L, Wang L, Cheng, et al. Epidemiological survey of hemodialysis patients in Shanxi Province from 2010 to 2012. Chin J Nephrol. 2014;30(02):123–27. Jing Li L, Wang L, Cheng, et al. Epidemiological survey of hemodialysis patients in Shanxi Province from 2010 to 2012. Chin J Nephrol. 2014;30(02):123–27.
16.
go back to reference Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012;7(1):123–30.CrossRefPubMed Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012;7(1):123–30.CrossRefPubMed
17.
go back to reference Takeda K, Harada A, Okuda S, Fujimi S, Oh Y, Hattori F, et al. Sudden death in chronic dialysis patients. Nephrol Dial Transplant. 1997;12(5):952–55.CrossRefPubMed Takeda K, Harada A, Okuda S, Fujimi S, Oh Y, Hattori F, et al. Sudden death in chronic dialysis patients. Nephrol Dial Transplant. 1997;12(5):952–55.CrossRefPubMed
19.
go back to reference Lim WH, Johnson DW, Hawley C, Lok C, Polkinghorne KR, Roberts MA, et al. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk. Med J Aust. 2018;209(10):440–46.CrossRefPubMed Lim WH, Johnson DW, Hawley C, Lok C, Polkinghorne KR, Roberts MA, et al. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk. Med J Aust. 2018;209(10):440–46.CrossRefPubMed
20.
go back to reference Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease.
21.
go back to reference Zhao X, Wang Y, Gan L, et al. Changes in the demographics and etiological composition of new maintenance hemodialysis patients in Beijing. Chin J Blood Purif. 2014;13(03):185–89. Zhao X, Wang Y, Gan L, et al. Changes in the demographics and etiological composition of new maintenance hemodialysis patients in Beijing. Chin J Blood Purif. 2014;13(03):185–89.
Metadata
Title
Epidemiological analysis of death among patients on maintenance hemodialysis: results from the beijing blood purification quality Control and Improvement Center
Authors
Jing Liu
Huixian Zhang
Zongli Diao
Wang Guo
Hongdong Huang
Li Zuo
Wenhu Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03271-6

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine